Ocugen (OCGN) Cash & Equivalents (2013 - 2026)
Ocugen's Cash & Equivalents came in at $100.1 million for Q2 2026, up 270.6% from $27.01 million a year earlier.
Powered by 
Analysis
Ocugen (OCGN) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Ocugen's Cash & Equivalents was $18.57 million.
- Cash & Equivalents carries a five-year compound annual growth rate of -5.0% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $39.46 million in FY2023 (-49.1%), $77.56 million in FY2022 (-18.3%) and $94.96 million in FY2021 (+295.0%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q3 2022.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2021 (growth of 461.9%), and the weakest in Q2 2024 (a decline of 77.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Ocugen | 322.34 Mn | 87.56 Mn | - | 24.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 24.63 Mn |
| Jun 30, 2026 | 100.10 Mn |
| Mar 31, 2026 | 31.86 Mn |
| Dec 31, 2025 | 18.57 Mn |
| Sep 30, 2025 | 32.57 Mn |
| Jun 30, 2025 | 27.01 Mn |
| Mar 31, 2025 | 37.80 Mn |
| Dec 31, 2024 | 58.51 Mn |
| Sep 30, 2024 | 38.70 Mn |
| Jun 30, 2024 | 15.70 Mn |
| Mar 31, 2024 | 26.40 Mn |
| Dec 31, 2023 | 39.46 Mn |
| Sep 30, 2023 | 53.48 Mn |
| Jun 30, 2023 | 70.58 Mn |
| Mar 31, 2023 | 68.26 Mn |
| Dec 31, 2022 | 77.56 Mn |
| Sep 30, 2022 | 101.60 Mn |
| Jun 30, 2022 | 115.01 Mn |
| Mar 31, 2022 | 129.77 Mn |
| Dec 31, 2021 | 94.96 Mn |
API Access
Ocugen Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OCGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "OCGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=OCGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();